期刊文献+

沉默AFAP-1L2对胃癌MKN-28细胞的生物学影响 被引量:2

The biological effects on gastric MKN-28 cells by silencing AFAP-1L2
下载PDF
导出
摘要 目的:探讨AFAP-1L2对胃癌MKN-28细胞的生物学影响。方法:siRNA干扰AFAP-1L2;CCK-8检测沉默AFAP-1L2后细胞的增殖情况;免疫荧光分析各组细胞的凋亡率;Transwell小室观察细胞的侵袭情况;Real time-PCR检测细胞中基因的表达情况。结果:siRNA有效干扰了AFAP-1L2的表达;沉默AFAP-1L2细胞组的细胞增殖明显受到抑制(P<0.05);siRNA-AFAP-1L2组细胞的凋亡率与其他组比较,凋亡率增高;细胞的侵袭情况,沉默AFAP-1L2明显抑制了细胞的侵袭,与其他两组比较差异显著(P<0.05);ERK1/2、p-ERK1/2和Bcl-2的表达水平,均是siRNA-AFAP-1L2细胞组低于其他两组(P<0.05)。结论:沉默AFAP-1L2抑制了胃癌MKN-28细胞的增殖,诱导细胞的凋亡,抑制了细胞的侵袭和抗凋亡基因的表达,AFAP-1L2可以通过ERK1/2途径发挥作用,为肿瘤的靶向治疗提供一定的理论依据。 Objective: To explore the biological effects on gastric MKN- 28 cells by AFAP- 1L2. Methods: siRNA interfer AFAP- 1L2. Using CCK- 8 to detect the proliferation of cells with AFAP- 1L2 silence. To analyse the condition of cell apoptosis by immunofluroescence. Using Transwell to detect the invasion ability. The expression of genes in MKN- 28 cells were analysed by Real time- PCR. Results: siRNA effectively interfered the expression of AFAP- 1L2. Cell proliferation was significantly suppressed in siRNA- AFAP- 1L2 cell group( P < 0. 05). The apoptosis rate of siRNA- AFAP- 1L2 was significantly higher than other groups. The cell counts of siRNA- AFAP- 1L2 group was lower than other groups( P < 0. 05). Real time- PCR showed that the expression of ERK1 /2,p- ERK1 /2and Bcl- 2 in siRNA- AFAP- 1L2 group was lower than those in other groups( P < 0. 05). Conclusion: Silence of AFAP- 1L2 inhibited gastric cancer MKN- 28 cell proliferation and induced the apoptosis of cells,inhibited invasion and antiapoptotic gene expression,AFAP- 1L2 may play a role by ERK1 /2 signaling pathway,these results provided certain theoretical basis for targeting therapy of gastric cancer.
出处 《现代肿瘤医学》 CAS 2016年第11期1691-1694,共4页 Journal of Modern Oncology
基金 辽宁省医学高峰建设项目(编号:2010017)
关键词 胃癌 肌动蛋白丝相关蛋白1相似蛋白 ERK1/2 BCL-2 gastric cancer AFAP-1L2 ERK1 /2 Bcl-2
  • 相关文献

参考文献10

  • 1Shiozaki Atsushi,Shen-Tu Grace,Bai Xiaohui,Iitaka Daisuke,De Falco Valentina,Santoro Massimo,Keshavjee Shaf,Liu Mingyao.XB130 mediates cancer cell proliferation and survival through multiple signaling events downstream of Akt. PloS one . 2012
  • 2Shi Min,Huang Weizhen,Lin Li,Zheng Dayong,Zuo Qiang,Wang Lin,Wang Nina,Wu Yajun,Liao Yulin,Liao Wangjun.Silencing of XB130 is associated with both the prognosis and chemosensitivity of gastric cancer. PloS one . 2012
  • 3Shiozaki Atsushi,Liu Mingyao.Roles of XB130, a novel adaptor protein, in cancer. Journal of clinical bioinformatics . 2011
  • 4Musazzi L,Seguini M,Mallei A,et al.Time-dependent activation of MAPK/Erk1/2 and Akt/GSK3 cascades:modulation by agomelatine. BMC Neuroscience . 2014
  • 5Atsushi Shiozaki,Monika Lodyga,Xiao-Hui Bai,Jeya Nadesalingam,Takeshi Oyaizu,Daniel Winer,Sylvia L. Asa,Shaf Keshavjee,Mingyao Liu.XB130, a Novel Adaptor Protein, Promotes Thyroid Tumor Growth[J]. The American Journal of Pathology . 2011 (1)
  • 6Ahmedin Jemal,Freddie Bray,Melissa M. Center.Global Cancer Statistics. CA-A CANCER JOURNAL FOR CLINICIANS . 2011
  • 7Jae-Kyung Won,Hee Won Yang,Sung-Young Shin.The crossregulation between ERK and PI3K signaling pathways determines the tumoricidal efficacy of MEK inhibitor. JOURNAL OF MOLECULAR CELL BIOLOGY . 2012
  • 8Shi M,Zheng D,Sun L,et al.XB130 promotes proliferation and invasion of gastric cancer cells. Journal of Translational Medicine . 2014
  • 9Takeshita H,Shiozaki A,Bai XH,Iitaka D,Kim H,Yang BB,Keshavjee S,Liu M.XB130,a new adaptor protein,regulates expression of tumor suppressive micro RNAs in cancer cells. PLo S One . 2013
  • 10Atsushi Shiozaki,Toshiyuki Kosuga,Daisuke Ichikawa,Shuhei Komatsu,Hitoshi Fujiwara,Kazuma Okamoto,Daisuke Iitaka,Shingo Nakashima,Hiroki Shimizu,Takeshi Ishimoto,Maki Kitagawa,Yoshito Nakou,Mitsuo Kishimoto,Mingyao Liu,Eigo Otsuji.??XB130 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma(J)Annals of Surgical Oncology . 2013 (9)

共引文献9

同被引文献11

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部